With over 65 years combined experience, we have a long track record of delivering timely solutions for our clients.
Market access refers to the process of ensuring that your products or services are available, affordable, and reimbursed by payers, such as insurance companies and government agencies. It involves understanding the needs of various stakeholders, including patients, healthcare providers, payers, and policymakers, and developing strategies to overcome barriers and achieve market acceptance.
We offer a wide range of market access strategy services tailored to meet your unique needs:
- Market Research and Analysis: We conduct in-depth market research and analysis to understand the dynamics of your target market. Our team assesses market trends, competitive landscape, patient needs, and reimbursement environment to identify opportunities and challenges. This research forms the foundation for developing a robust market access strategy.
- Pricing and Reimbursement Strategy: Determining the optimal pricing and reimbursement strategy is critical for successful market access. We help you navigate the complex pricing landscape, taking into account factors such as product value, competitive pricing, payer expectations, and cost-effectiveness. Our experts collaborate with you to develop a pricing and reimbursement strategy that balances affordability with market sustainability.
- Market Access Planning and Execution: Developing a comprehensive market access plan is crucial for a successful product launch. We work closely with you to develop a tailored market access strategy, including stakeholder mapping, market segmentation, and value proposition development. Our team assists with the execution of the plan, providing guidance on key activities such as formulary submissions, payer engagement, and market access communications.
- Health Economics and Outcomes Research (HEOR): Demonstrating the value and cost-effectiveness of your products or services is essential for market acceptance. Our HEOR experts conduct economic evaluations, comparative effectiveness studies, and patient-reported outcome assessments to generate evidence of clinical and economic benefits. This evidence supports reimbursement negotiations and informs payer decision-making.
- Health Technology Assessment (HTA) Support: HTA agencies play a critical role in determining the value and reimbursement of healthcare interventions. We provide support throughout the HTA process, including evidence generation, dossier development, and strategic engagement with HTA bodies. Our goal is to help you navigate the HTA landscape and optimise your chances of favorable HTA outcomes.
To find out more and discuss your project, please contact us.